Wang Janice, Wong Winifred P, Link Emma O, Olivares Shantel, Adelman Cade T, Henkel Anne S, El Muayed Malek
Division of Endocrinology, Metabolism and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Masters of Biomedical Studies Program, Drexel University, Philadelphia, PA 19104, USA.
Biol Methods Protoc. 2021 Feb 9;6(1):bpab002. doi: 10.1093/biomethods/bpab002. eCollection 2021.
Quantifying the ratio of alternatively spliced mRNA variants of genes with known alternative splicing variants is highly relevant for many applications. Herein, we describe the validation of a quantitative PCR design for the simplified quantification of known mRNA splice variants. The assay uses a single-common primer pair, dual probe design for the determination of splicing variants in a single well configuration. We used murine XBP-1 splicing variants, XBP-1S and XBP-1U, to validate and demonstrate the performance characteristics of this approach. Using synthetic XBP-1S and XBP-1U cDNA as well as cDNA synthesized from mouse beta-cell line MIN6, we established the performance parameters and dynamic range of the assay. Reliable quantification of both variants at varying concentration gradients was shown. No cross detection of XBP-1U by the XBP-1S probe was detected and only marginal XBP-1S cross detection by the XBP-1U probe was detected at high concentration gradients that are unlikely to be relevant. We demonstrated that the assay accurately detected changes of XBP-1 splice variants in mouse liver subjected to pharmacologically induced ER stress without the need for normalization to a reference gene.
对具有已知可变剪接变体的基因的可变剪接 mRNA 变体比例进行定量,在许多应用中都具有高度相关性。在此,我们描述了一种定量 PCR 设计的验证,用于简化已知 mRNA 剪接变体的定量。该检测方法使用一对单一通用引物、双探针设计,以在单孔配置中测定剪接变体。我们使用小鼠 XBP-1 剪接变体 XBP-1S 和 XBP-1U 来验证并展示这种方法的性能特征。使用合成的 XBP-1S 和 XBP-1U cDNA 以及从小鼠β细胞系 MIN6 合成的 cDNA,我们确定了该检测方法的性能参数和动态范围。结果显示在不同浓度梯度下对两种变体均能进行可靠定量。未检测到 XBP-1S 探针交叉检测到 XBP-1U,并且在不太可能相关的高浓度梯度下,仅检测到 XBP-1U 探针有少量 XBP-1S 交叉检测。我们证明,该检测方法能够准确检测在药理学诱导的内质网应激下小鼠肝脏中 XBP-1 剪接变体的变化,而无需对参考基因进行标准化。